Mangalam Organics Limited

Mangalam Organics Limited

MANORG.NS
Mangalam Organics LimitedIN flagNational Stock Exchange of India
538.90
INR
+10.40
- -
4.62BMarket Cap
Mangalam Organics Limited
MANORG.NS
(National Stock Exchange of India)

Recent

price

538.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
219.39
243.27
231.45
255.9
263.94
186.47
196.54
267.32
492.96
437.3
394.93
572.89
575.08
576.24
614.27
- -
715.66
Revenue per Share
11.1
3.7
3.84
5.28
4.64
-11.42
5.34
15.97
84.35
55.97
98.99
62.75
-31.79
5.14
14.6
- -
29.61
Basic EPS, GAAP
-18.39
-12.6
20.47
-8.77
-9.31
10.8
20.17
19.4
1.89
39.73
-3.22
-214.92
42.22
38.77
-87.06
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
1.2
1.17
1
1.5
1.5
- -
- -
- -
- -
Dividend per Share
34.62
35.85
39.69
44.97
46.57
35.14
40.42
56.24
139.13
194.29
292.11
353.29
320.15
325.95
9.93
- -
9.84
Book Value per Share
46.91
48.31
51.05
56.33
57.95
46.52
51.8
67.62
140.87
196.04
293.86
355.04
321.97
327.63
339.69
- -
366.09
Tangible Book Value per Share
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
- -
9
Basic Weighted Avg Shares
1,908
2,202
2,095
2,317
2,389
1,688
1,779
2,420
4,246
3,745
3,382
4,906
4,925
4,935
5,300
6,226
6,226
Sales/Revenue/Turnover
10.14
4.49
5.04
6.31
4.15
-17.97
4.16
8.15
24.41
20.69
33.88
15.51
-3.95
3.82
7.12
9.68
9.68
Operating Margin (%)
36
38
43
47
62
53
53
55
62
90
135
150
175
198
208
276
276
Depreciation Expense
96
33
35
48
42
-103
48
145
727
479
848
537
-272
44
126
258
258
Net Income, GAAP
36
- -
28.63
33.17
38.63
- -
- -
21.39
28.5
23.8
25.83
26.59
- -
- -
24.2
22.65
22.65
Effective Tax Rate (%)
5.06
1.52
1.66
2.07
1.76
-6.13
2.72
5.97
17.11
12.8
25.06
10.95
-5.53
0.89
2.38
4.14
4.14
Profit Margin (%)
57
50
19
109
202
322
236
258
757
744
1,367
1,856
774
442
259
478
478
Working Capital
66
61
43
30
93
233
110
8
63
88
- -
521
415
208
345
571
571
LT Debt
408
437
462
510
525
421
469
612
1,213
1,679
2,517
3,041
2,758
2,806
2,932
3,186
3,186
Total Equity
22.1
- -
8.68
10.49
5.29
- -
- -
15.34
53.55
32.41
36.32
14.09
- -
- -
5.61
7.5
7.5
Return on Invested Capital (%)
25.77
- -
4.57
6.57
7.05
- -
- -
18.03
57.37
28.98
36.96
14.21
- -
- -
7.88
14.67
14.67
Return on Capital (%)
36.28
10.71
10.17
12.48
10.14
-27.96
14.13
33.04
85.1
33.49
40.7
19.45
-9.44
1.59
8.76
300.74
300.74
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
3,007
- -
3,020
LT Borrowings
513
- -
550
LT Finance Leases
- -
- -
22
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
- -
9
Market Capitalization
4,609
4,219
3,193

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
3,958
- -
4,005
Cash, Cash Equivalents & STI
412
- -
205
Accounts Receivable, Net
783
- -
587
Inventories
2,571
- -
3,001
Total Current Liabilities
3,631
- -
3,527
Payables & Accruals
- -
- -
- -
ST Debt
3,007
- -
3,020
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.48%
5.29%
8.66%
Free Cash Flow
797.61%
1,219.68%
-16.69%
Net Income, GAAP
48.47%
-2.62%
104.46%
Sales/Revenue/Turnover
16.59%
14.1%
17.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,089
1,689
1,106
1,051
4,935
2025
1,180
1,383
1,239
1,498
5,300
2026
1,466
1,581
1,643
1,536
6,226

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.36
0.74
1.05
- -
5.14
2025
1.95
2.51
4.25
5.92
14.6
2026
14.28
3.75
5.07
6.56
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Mangalam Organics Limited Mangalam Organics Limited manufactures pine chemicals, specializing in terpene derivatives and synthetic resins. The company produces camphor, camphene, dipentene, isobornyl acetate, isoborneol flakes (Bhimseni camphor), sodium acetate trihydrate, terpineol, camphor oil, and pine tar in its terpene chemistry segment; terpene phenolic resin, alkyl phenolic resin, glycerol modified ester gum, and penta modified ester gum in its resin products segment. These products serve applications in religious use, healthcare and hygiene items, fragrances and flavors, paints, cleaning agents, textiles, dyes, leather tanning, adhesives, tires, rubbers, and chewing gum. Mangalam Organics Limited operates a manufacturing facility in Kumbhivali Village, Savroli-Kharpada Road, Khalapur, Khopoli, Raigad District, Maharashtra, India, with head office at 812/813 Tulsiani Chambers, 212 Nariman Point, Mumbai; it sources turpentine globally from Brazil, Argentina, Chile, USA, Russia, Indonesia, Vietnam, China, Portugal, and Spain, while selling domestically through eight offices across India and exporting to Europe, USA, Africa, Middle East, and Southeast Asia. Incorporated in 1981 as a BSE and NSE listed entity (ticker: MANORG.NS), the company achieved world's largest camphor production capacity of 10,000 MT per annum in 2022 via expansion. In recent developments, Mangalam Organics Limited transferred its retail business to 100% subsidiary Mangalam Brands Private Limited (MBPL, formerly CamPure Private Limited, incorporated 2020) in FY2022-23, enabling MBPL to drive B2C growth for brands Mangalam camphor tablets (launched 2013) and CamPure homecare products (launched 2017) like air purifiers, mosquito repellents, cones, sticks, surface cleaners, and vaporizers across general trade in 18 states, modern trade in 4,000 stores, e-commerce, CSD, and exports; MBPL targets Rs. 500 crore revenue in 3-4 years. The company enhanced terpene yields, energy efficiency, and cost measures in FY2024 amid falling camphor prices, turning a prior-year loss into Rs. 4.08 crore PAT and Rs. 36.91 crore EBITDA on Rs. 407.92 crore revenue (94% terpenes B2B, 6% resins B2B). Mangalam Organics Limited pursues terpene intermediates like camphene for paints/resins/fragrances and strategies for bespoke resins in tyres/adhesives/printing inks; it approved Rs. 175 crore related party transactions with MBPL for FY2025, borrowing up to Rs. 1,000 crore, cost auditor remuneration, independent director appointment, and managing director remuneration adjustments.